Bcl-2 gene family in endocrine pathology: A review

Endocrine Pathology

Volumn 11, Issue 3, 2000, Pages 205-213

  Nikiforos, K ^a,b   Kontogeorgos, George ^a,b  

^a Amalia Fleming Hospital   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

Author keywords

Apoptosis; Bax; Bcl 2; Immunohistochemistry; Tumors

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; DIMERIZATION; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MULTIGENE FAMILY; NEUROENDOCRINE TUMOR; PATHOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW;

EID: 0033745990     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/ep:11:3:205     Document Type: Review

References (57)

1. Cell death in normal vertebrate ontogeny
2. Death in embryonic systems
3. Programmed cell death, apoptosis and killer genes
4. Apoptosis in endocrine glands
5. Investigation of the subcellular distribution of the Bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and the outer mitochondrial membranes
6. Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma
7. Expression of the proto-oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
8. Bcl-2 protein in non-small cell lung carcinoma
9. BCL-2 expression in adult and embryonic non-haematopoietic tissues
10. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity
11. Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients
12. Bcl-2 and the regulation of programmed cell death
13. The BCL-2 gene family
14. The protooncogene bcl-2 and its role in regulating apoptosis
15. BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax
16. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry
17. Regulators of cell death
18. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines
19. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene
20. Bcl-2: An antidote to programmed cell death
21. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland
22. Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland
23. Susceptibility of differentiated thyrocytes in primary culture to undergo apoptosis after exposure to hydrogen peroxide: Relation with the level of expression of apoptosis regulatory proteins, Bcl-2 and Bax
24. Apoptosis in thyroid neoplasms: Relationship with p53 and bcl-2 expression
25. Expression of apoptosis-related proteins in thyroid tumors and thyroid carcinoma cell lines
26. bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas
27. Prognostic value of bcl-2 immunoreactivity in medullary thyroid carcinoma
28. Apoptosis and proliferation in thyroid carcinoma: Correlation with bcl-2 and p53 protein expression
29. Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid
30. Bcl-2 and Bax expression in thyroid tumours. An immunohistochemical and western blot analysis
31. Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development
32. Parathyroid hormone-related protein (PTHrP) as a regulating factor of endochondral bone formation
33. Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues
34. Detection of apoptotic cells and expression of Ki-67 antigen, Bcl-2, p53 oncoproteins in human parathyroid adenoma
35. The role of prognostic markers (MIB-1 RB, and bcl-2) in the diagnosis of parathyroid tumors
36. bcl-2 expression in normal adrenal glands and in adrenal neoplasms
37. The possible role of apoptosis-suppressing genes, bcl-2 and mcl-1/EAT in human adrenal tumors
38. Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl- 1 in control of programmed cell death in vivo
39. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family
40. Islet morphogenesis and stem cell markers in rat pancreas
41. Analysis of BAX expression in human tissues using the anti-BAX, 4F11 monoclonal antibody on paraffin sections
42. + signaling in apoptosis of pancreatic cells and the impairment of glucose-induced insulin secretion
43. Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: Inhibition by Bcl-2
44. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction
45. Molecular and cellular responses to DNA damage in a murine pituitary adenoma cell line
46. Apoptosis in nontumorous and neoplastic human pituitaries: Expression of the Bcl-2 family of proteins
47. Bcl-2 and bax expression and correlation with apoptosis in pituitary adenomas
48. Apoptosis in human pituitary adenomas: A morphologic and in situ end-labeling study
49. Apoptosis-related factors p53, bcl-2 and bax in neuroendocrine lung tumors
50. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung
51. Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS
52. Bcl-2 regulates neural differentiation
53. Different expression of bcl-2 oncoprotein levels in neuroblastoma and other human tumor cell lines on neural origin
54. Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas
55. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein of bclp
56. Differences of bcl-2 protein expression between Merkel cells and Merkel cell carcinomas
57. Bcl-2 expression in human melanocytes and melanocytic tumors